CAPOS syndrome
CAPOS syndrome is a rare genetic disorder characterized by Cerebellar ataxia, Areflexia, Pes cavus, Optic atrophy, and Sensorineural hearing loss. The syndrome was first described in 1996 by Nicolaides and Appleton. The name CAPOS is an acronym derived from the initial letters of these five main features.
Clinical Features[edit | edit source]
Cerebellar ataxia is a form of ataxia originating in the cerebellum. It results in unsteady movements and a lack of coordination.
Areflexia is a condition in which the muscles do not respond to stimuli as they should. This can lead to difficulties with movement and coordination.
Pes cavus is a high arch of the foot that does not flatten with weight bearing. This can lead to instability and a variety of foot problems.
Optic atrophy refers to the degeneration of the optic nerve, which can lead to vision loss.
Sensorineural hearing loss is a type of hearing loss in which the root cause lies in the inner ear or sensory organ (cochlea and associated structures) or the vestibulocochlear nerve (cranial nerve VIII).
Genetics[edit | edit source]
CAPOS syndrome is caused by mutations in the ATP1A3 gene. This gene provides instructions for making a protein that is found in nerve cells, where it helps maintain the proper balance of charged atoms (ions) inside these cells. Mutations in the ATP1A3 gene alter the function of this protein, which disrupts ion balance in nerve cells and leads to the features of CAPOS syndrome.
Diagnosis and Treatment[edit | edit source]
Diagnosis of CAPOS syndrome is based on the presence of the characteristic clinical features. Genetic testing can confirm the diagnosis. Treatment is symptomatic and supportive, focusing on managing each of the individual symptoms.
See Also[edit | edit source]
- Genetic disorder
- Cerebellar ataxia
- Areflexia
- Pes cavus
- Optic atrophy
- Sensorineural hearing loss
- ATP1A3
NIH genetic and rare disease info[edit source]
CAPOS syndrome is a rare disease.
| CAPOS syndrome Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
